tirzepatide and rheumatoid arthritis Concomitant ixekizumab significantly improved psoriatic disease activity and promoted weight reduction versus ixekizumab alone in adults with PsA and obesity or overweight in the TOGETHER-PsA phase 3b trial. Read Tirzepatide for Joint Pain &

Many patients report significant improvement or complete resolution of nausea and related symptoms within 23 months of maintaining a stable dose

While eating less helps create a calorie deficit, it can also lead to: Muscle loss Fatigue Hair thinning Nutrient deficiencies Constipation Slower metabolism That's why the goal isn't just to eat less

Clinical Efficacy Clinical trials demonstrate the potential of retatrutide to induce rapid weight loss

The loophole that keeps Empower operating Compounding pharmacies cannot produce exact copies of commercially available drugs when no shortage exists

Watch Part 1 GLP-1s: Overview and Q&A Watch Part 2 GLP-1s: Next Steps This webinar is intended for prescribers

One of Australias most popular research peptides from Neurogen Research